263 related articles for article (PubMed ID: 23344789)
1. Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?
Shah AH; Snelling B; Bregy A; Patel PR; Tememe D; Bhatia R; Sklar E; Komotar RJ
J Neurooncol; 2013 Apr; 112(2):141-52. PubMed ID: 23344789
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence.
Parvez K; Parvez A; Zadeh G
Int J Mol Sci; 2014 Jul; 15(7):11832-46. PubMed ID: 24995696
[TBL] [Abstract][Full Text] [Related]
3. Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis?
Caroline I; Rosenthal MA
J Clin Neurosci; 2012 May; 19(5):633-7. PubMed ID: 22321359
[TBL] [Abstract][Full Text] [Related]
4. Performance of SPECT in the differential diagnosis of glioma recurrence from radiation necrosis.
Zhang H; Ma L; Wu C; Xu BN
J Clin Neurosci; 2015 Feb; 22(2):229-37. PubMed ID: 25443083
[TBL] [Abstract][Full Text] [Related]
5. Role of circulating tumor cell detection in differentiating tumor recurrence from treatment necrosis of brain gliomas.
Gao F; Zhao W; Li M; Ren X; Jiang H; Cui Y; Lin S
Biosci Trends; 2021 May; 15(2):107-117. PubMed ID: 33952802
[TBL] [Abstract][Full Text] [Related]
6. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.
Mullins ME; Barest GD; Schaefer PW; Hochberg FH; Gonzalez RG; Lev MH
AJNR Am J Neuroradiol; 2005 Sep; 26(8):1967-72. PubMed ID: 16155144
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
[TBL] [Abstract][Full Text] [Related]
8. Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.
Alexiou GA; Tsiouris S; Kyritsis AP; Voulgaris S; Argyropoulou MI; Fotopoulos AD
J Neurooncol; 2009 Oct; 95(1):1-11. PubMed ID: 19381441
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury.
Hein PA; Eskey CJ; Dunn JF; Hug EB
AJNR Am J Neuroradiol; 2004 Feb; 25(2):201-9. PubMed ID: 14970018
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging.
Bisdas S; Naegele T; Ritz R; Dimostheni A; Pfannenberg C; Reimold M; Koh TS; Ernemann U
Acad Radiol; 2011 May; 18(5):575-83. PubMed ID: 21419671
[TBL] [Abstract][Full Text] [Related]
11. Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review.
Furuse M; Nonoguchi N; Yamada K; Shiga T; Combes JD; Ikeda N; Kawabata S; Kuroiwa T; Miyatake SI
Radiat Oncol; 2019 Feb; 14(1):28. PubMed ID: 30728041
[TBL] [Abstract][Full Text] [Related]
12. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
14. Pseudoprogression in high-grade glioma.
Knudsen-Baas KM; Moen G; Fluge Ø; Storstein A
Acta Neurol Scand Suppl; 2013; (196):31-7. PubMed ID: 23190289
[TBL] [Abstract][Full Text] [Related]
15. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
Yang I; Huh NG; Smith ZA; Han SJ; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):181-6. PubMed ID: 19944976
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT.
Tie J; Gunawardana DH; Rosenthal MA
J Clin Neurosci; 2008 Dec; 15(12):1327-34. PubMed ID: 18845440
[TBL] [Abstract][Full Text] [Related]
18. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
Tsien C; Galbán CJ; Chenevert TL; Johnson TD; Hamstra DA; Sundgren PC; Junck L; Meyer CR; Rehemtulla A; Lawrence T; Ross BD
J Clin Oncol; 2010 May; 28(13):2293-9. PubMed ID: 20368564
[TBL] [Abstract][Full Text] [Related]
19. Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis.
Zhang H; Ma L; Wang Q; Zheng X; Wu C; Xu BN
Eur J Radiol; 2014 Dec; 83(12):2181-2189. PubMed ID: 25452098
[TBL] [Abstract][Full Text] [Related]
20. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
